Cellevate Overview

  • Founded
  • 2014
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Cellevate General Information


Developer of cell culture systems. The company creates porous and consistent networks of nanofibers through a patented manufacturing process.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Primary Office
  • Medicon Village
  • Scheelev. 2
  • 223 63 Lund
  • Sweden
+46 070-490 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellevate Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Cellevate’s complete valuation and funding history, request access »

Cellevate Patents

Cellevate Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3356583-A1 Method and arrangement for electrospinning of nanofibers Withdrawn 28-Sep-2015 0000000000

Cellevate Executive Team (2)

Name Title Board Seat Contact Info
Karl Ekman Co-Founder & Chief Executive Officer
Erik Fredstorp Co-Founder & Research and Development Engineer
To view Cellevate’s complete executive team members history, request access »

Cellevate Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellevate Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
SmiLe Incubator Accelerator/Incubator 000 0000 000000 0
To view Cellevate’s complete investors history, request access »